Literature DB >> 31085088

Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer.

Ho Lam Chan1, Lluis Morey2.   

Abstract

Polycomb-group (PcG) complexes are multiprotein, evolutionarily conserved epigenetic machineries that regulate stem cell fate decisions and development, and are also implicated in cancer and other maladies. The PcG machinery can be divided into two major complexes: Polycomb repressive complex 1 and 2 (PRC1 and PRC2). Traditionally, PcG complexes have been associated with maintenance of gene repression mainly via histone-modifying activities. However, during the last years, increasing evidence indicates that the PcG complexes can also positively regulate gene transcription and modify non-histone substrates in multiple biological processes, cellular stages, and cancers. In this review, we will illustrate recent findings in PcG-mediated gene regulation, with special focus on the recently described non-classical functions of PcG complexes in stem cells and cancer.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PRC1; PRC2; gene transcription; methylation; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31085088     DOI: 10.1016/j.tibs.2019.04.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  40 in total

Review 1.  Reprogramming: identifying the mechanisms that safeguard cell identity.

Authors:  Justin Brumbaugh; Bruno Di Stefano; Konrad Hochedlinger
Journal:  Development       Date:  2019-12-02       Impact factor: 6.868

2.  A Polycomb domain found in committed cells impairs differentiation when introduced into PRC1 in pluripotent cells.

Authors:  Elizabeth S Jaensch; Jinjin Zhu; Jesse C Cochrane; Sharon K Marr; Theresa A Oei; Manashree Damle; Ethan Z McCaslin; Robert E Kingston
Journal:  Mol Cell       Date:  2021-10-11       Impact factor: 17.970

3.  [PCGF1 is highly expressed in rectal adenocarcinoma and silencing PCGF1 inhibits proliferation of rectal adenocarcinoma cells in vitro].

Authors:  Y Zeng; R Fan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

Review 4.  Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies.

Authors:  Hyunkoo Kang; Haksoo Lee; Dahye Kim; Byeongsoo Kim; JiHoon Kang; Hae Yu Kim; HyeSook Youn; BuHyun Youn
Journal:  Biomedicines       Date:  2022-06-02

Review 5.  The control of polycomb repressive complexes by long noncoding RNAs.

Authors:  Jackson B Trotman; Keean C A Braceros; Rachel E Cherney; McKenzie M Murvin; J Mauro Calabrese
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-04-16       Impact factor: 9.957

6.  Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells in vitro.

Authors:  Abdulhameed Al-Ghabkari; Aru Narendran
Journal:  Cancer Biol Ther       Date:  2021-05-12       Impact factor: 4.742

7.  CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.

Authors:  Zhengnan Huang; Yilin Yan; Zhen Zhu; Jiakuan Liu; Xiao He; Sumiya Dalangood; Meiqian Li; Mingyue Tan; Jinming Cai; Pengfei Tang; Ruimin Huang; Bing Shen; Jun Yan
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

8.  Boundaries potentiate polycomb response element-mediated silencing.

Authors:  Maksim Erokhin; Fedor Gorbenko; Dmitry Lomaev; Marina Yu Mazina; Anna Mikhailova; Azat K Garaev; Aleksander Parshikov; Nadezhda E Vorobyeva; Pavel Georgiev; Paul Schedl; Darya Chetverina
Journal:  BMC Biol       Date:  2021-06-02       Impact factor: 7.431

Review 9.  Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges.

Authors:  Bo Qiu; Cassie Kline; Sabine Mueller
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

10.  Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8*.

Authors:  Natalia Milosevich; Chelsea R Wilson; Tyler M Brown; Aktan Alpsoy; Sijie Wang; Katelyn E Connelly; Kirsten A D Sinclair; Felino R Ponio; Rebecca Hof; Emily C Dykhuizen; Fraser Hof
Journal:  ChemMedChem       Date:  2021-07-23       Impact factor: 3.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.